Australia markets close in 48 minutes
  • ALL ORDS

    7,304.00
    -8.00 (-0.11%)
     
  • ASX 200

    7,045.00
    -10.40 (-0.15%)
     
  • AUD/USD

    0.7735
    +0.0028 (+0.36%)
     
  • OIL

    61.91
    +0.48 (+0.78%)
     
  • GOLD

    1,784.90
    +2.90 (+0.16%)
     
  • BTC-AUD

    63,431.22
    -6,848.73 (-9.74%)
     
  • CMC Crypto 200

    1,106.77
    -136.29 (-10.96%)
     
  • AUD/EUR

    0.6430
    +0.0022 (+0.34%)
     
  • AUD/NZD

    1.0771
    +0.0015 (+0.14%)
     
  • NZX 50

    12,650.64
    +73.16 (+0.58%)
     
  • NASDAQ

    13,762.36
    -172.79 (-1.24%)
     
  • FTSE

    6,938.24
    +42.95 (+0.62%)
     
  • Dow Jones

    33,815.90
    -321.41 (-0.94%)
     
  • DAX

    15,320.52
    +124.55 (+0.82%)
     
  • Hang Seng

    28,960.71
    +205.37 (+0.71%)
     
  • NIKKEI 225

    28,956.78
    -231.39 (-0.79%)
     

Global Stents Market Report 2021-2027 - Trend of Coronary Stent Price Slashing and Increasing Competitiveness of Domestic Players in APAC Countries

Research and Markets
·7-min read

Dublin, March 05, 2021 (GLOBE NEWSWIRE) -- The "Global Stents Market, Forecast to 2027" report has been added to ResearchAndMarkets.com's offering.

The global stents market is expected to reach $13,522.8 million by 2027, growing at a mid single digit CAGR from 2020 to 2027. The market is segmented by product, material, application, end-users and geography.

Stents are the miniaturized, flexible or expandable tube like structures used to widen and establish patency of the clogged vascular or non-vascular tubular structures and to ensure steady flow of body fluids through them.

Compared to the traditional highly invasive surgical repair procedures, the current minimally invasive transcatheter therapeutic procedures with highly efficient, technologically advanced stent products assure patients and healthcare providers with improved efficiency, effectiveness and quicker restoration of the narrowed vessel's or duct's natural function.

Increased utilization of the various stent products for the numerous and varied types of vascular and non-vascular obstructive conditions and cerebral aneurysm among the patients, elevating inclination of the value centric global patient pool towards the minimally invasive, technologically advanced stent products with better therapeutic outcomes and the need to rapidly mitigate the clinical manifestations associated with blocked vascular and non-vascular hollow organs or weakened vascular bed, reduce hospitalization duration and ease and improve the patient's condition quickly through efficient and safer interventional products are fuelling the stents global market.

The stents global market is consolidated with few companies dominating and occupying major share of the market. Some of the leading players in stents market are Boston Scientific Corporation (U.S.), Abbott Laboratories (U.S.), Medtronic PLC (Ireland), Terumo Corporation (Japan), Cook Medical LLC (U.S.), Cardinal Health Inc. (U.S.), Becton, Dickinson and company (U.S.), B. Braun Melsungen AG (Germany), Biotronik SE & Co. KG (Germany), Blue Sail Medical Co. Ltd. (Biosensors International Pte. Ltd.) (China) and others.

Key Topics Covered:

1 Executive Summary

2 Introduction

3 Market Analysis
3.1 Introduction
3.2 Market Segmentation
3.3 Factors Influencing Market
3.3.1 Drivers and Opportunities
3.3.1.1 Escalating Prevalence of Vascular and Non-Vascular Stenotic Diseases and Cerebral Aneurysm
3.3.1.2 Elevating Inclination Towards Minimally Invasive Therapeutic Approaches
3.3.1.3 The Trend of Coronary Stent Price Slashing and Increasing Competitiveness of Domestic Players in APAC Countries
3.3.1.4 Emergence of Technologically Advanced Products
3.3.1.5 Escalating Geriatric Population and Feasibility of Drug Eluting Stents in Them
3.3.1.6 Acquisitions and Distribution Agreements to Open an Array of Opportunities for the Market to Flourish
3.3.1.7 Favourable Reimbursement Policies Escalating Stent Technology Diffusion in Developed Nations
3.3.2 Restraints and Threats
3.3.2.1 Stringent Regulatory Bodies Guiding Stent Manufacturers
3.3.2.2 The Threat of Commercialized Stent Recalls
3.3.2.3 Lack of Skilled, Experienced and Trained Healthcare Professionals
3.3.2.4 Adverse Effects of Stents
3.3.2.5 Concerns Over Irrational Stenting and Under-Performance of Stents in Complex Stenotic Diseases or Lesions
3.4 Regulatory Affairs
3.4.1 International Organization for Standardization
3.4.1.1 ISO 9001: 2015 Quality Management System
3.4.1.2 ISO 14644-1 Clean Room Standards
3.4.1.3 ISO 13485 Medical Devices
3.4.1.4 ISO 10993 Biological Evaluation of Medical Devices
3.4.1.5 ISO 14971: Risk Management of Medical Devices
3.4.1.6 ISO 25539-2: 2020 Cardiovascular Implants - Endovascular Devices - Part 2: Vascular Stents
3.4.1.7 ISO 25539-1
3.4.1.8 ISO 12417-1
3.4.1.9 ISO/TS 17137
3.4.1.10 ISO 17327-1
3.4.1.11 IEC 60601-1 Medical Electrical Equipment Standard
3.4.2 ASTM International Standards
3.4.3 U.S.
3.4.4 Canada
3.4.5 Europe
3.4.6 Japan
3.4.7 China
3.4.8 India
3.5 Technological Advancements
3.5.1 Introduction
3.5.2 Smart Stents
3.5.3 3D-Printed Stents
3.5.4 Indirect 4D Printing and Microstents
3.5.5 Nanocoated Non-Drug Eluting Stent and Ultrashort DAPT
3.5.6 Bioengineered Stents
3.5.7 Gene Eluting Stents (GES)
3.5.8 Bioresorbable Stents
3.6 Stents Coating Materials
3.6.1 Inorganic Coating Materials
3.6.2 Organic Coating Materials
3.6.3 Biological Coating Materials or Biocoatings
3.6.4 Chemotheraputics or Drugs
3.7 Porter's Five Force Analysis
3.8 Supply Chain Analysis
3.9 Reimbursement Scenario
3.10 Patent Trends
3.11 Regulatory Approval Analysis
3.12 Clinical Trials
3.13 Market Share Analysis by Major Players
3.13.1 Stents Global Market Share Analysis
3.13.2 Coronary Stents Global Market Share Analysis
3.13.3 Peripheral Stents Global Market Share Analysis
3.13.4 Neurovascular Stents Global Market Share Analysis
3.13.4.1 Flow Diverters Global Market Share Analysis
3.13.4.2 Intracranial Stent Global Market Share Analysis
3.13.4.3 Carotid Stent Global Market Share Analysis
3.13.5 Gastrointestinal Stents Global Market Share Analysis
3.13.6 Drug Eluting Stents Global Market Share Analysis
3.14 Stents - Number of Procedures by Region
3.15 Stents Company Comparison Table by Revenue, Product, Product Type, Application, Material and Indication

4 Stents Global Market, by Product
4.1 Introduction
4.2 Bare Metal Stents
4.3 Drug Eluting Stents
4.4 Bioresorbable Stents
4.5 Other Stents

5 Stents Global Market, by Material
5.1 Introduction
5.2 Metal Alloy Based Stents
5.3 Polymer Based Stents

6 Stents Global Market, by Application
6.1 Introduction
6.2 Vascular Stents
6.3 Non-Vascular Stents

7 Stents Global Market, by End-users
7.1 Introduction
7.2 Hospitals
7.3 Ambulatory Surgery Centers
7.4 Other End-users

8 Regional Analysis

9 Competitive Landscape
9.1 Introduction
9.2 Product Approval
9.3 Clinical Studies/Investigations
9.4 Product Launch
9.5 Acquisition
9.6 Other Developments

10 Major Companies

  • Abbott Laboratories

  • Braun Melsungen AG

  • Becton, Dickinson and Company

  • Biotronik SE & Co. KG

  • Blue Sail Medical Co. Ltd. (Biosensors International Pte. Ltd.)

  • Boston Scientific Corporation

  • Cardinal Health Inc.

  • Cook Medical LLC

  • Medtronic plc

  • Terumo Corporation

Companies Mentioned

  • Abbott Laboratories

  • Abbvie Inc.

  • Acandis GmbH

  • Accura Medizintechnik GmbH

  • Allium Ltd.

  • Alvimedica

  • AndraTec GmbH

  • Arterius Limited

  • B. Braun Melsungen AG

  • B.Braun Melsungen AG

  • Balt Extrusion

  • Balton Sp. z o.o.

  • Becton, Dickinson and Company

  • Bentley InnoMed GmbH

  • Bess AG

  • Bioteque Corporation

  • Biotronik SE & Co. KG

  • Blue Sail Medical Co. Ltd.

  • Boston Scientific Corporation

  • Cardinal Health Inc.

  • CeloNova BioSciences, Inc.

  • Conmed Corporation

  • Cook Medical LLC

  • Disa Vascular

  • Dispomedica GmbH

  • Elixir Medical Corporation

  • ELLA - CS, s.r.o

  • Endocor GmbH

  • EndoGI Medical

  • Eucatech AG

  • EuroCor Tech GmbH

  • GENOSS Co. Ltd.

  • Glaukos Corporation

  • Hexacath International

  • HydrUStent SA

  • InspireMD

  • Ivantis Inc.

  • iVascular S.L.U.

  • Kyoto Medical Planning Co. Ltd.

  • Lepu Medical Technology

  • M.I.TECH Co. Ltd.

  • Med pro Medical B.V.

  • Medas Inc.

  • Medicut Stent Technology GmbH

  • Medinol Ltd.

  • Medtronic plc

  • Meril Life Sciences Pvt. Ltd.

  • Merit Medical Systems Inc.

  • Merlin MD Pte. Ltd.

  • Micell Technologies, Inc.

  • Micro Science Medical AG

  • Micro-Tech

  • Microport Scientific Corporation

  • Nanostent

  • Numed Inc.

  • Olympus Corporation

  • Optimed Medizinische Instrumente GmbH

  • Opto Circuits

  • OrbusNeich Medical Company Limited

  • Palex Medical SA

  • Phenox GmbH

  • Plus medica Nordic AB

  • PNN Medical A/S

  • Poseidon Medical Inc.

  • Q3 Medical Devices Ltd.

  • Relisys Medical Devices Limited

  • REVA Medical Inc.

  • Rontis AG

  • Sahajanand Medical Technologies Pvt. Ltd.

  • Scitech Produtos Medicos SA

  • Silk Road Medical Inc.

  • Stening Srl

  • Svelte Medical Systems Inc.

  • Synlas GmbH & Co. KG

  • Taewoong Medical Co. Ltd.

  • Terumo Corporation

  • Thoracent, Inc.

  • Translumina Therapeutics

  • USM Healthcare Medical Devices Factory JSC

  • Vygon SA

  • W. L. Gore & Associates, Inc.

  • Wellinq Holding B.V.

  • Zhejiang Chuangxiang Medical Technology Co. Ltd.

For more information about this report visit https://www.researchandmarkets.com/r/68lqk3

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900